Saturday 17 October 2026
Export PPBT’s income statement to Excel — free account
Purple Biotech Ltd. Sponsored ADR
PPBT Healthcare Biotechnology
In the quarter to June 2026, EPS grew 110.2% and free cash flow fell 62.1%, each against the same quarter a year earlier.
1.14
0.09
−7.32%
Follow PPBT
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | — | — | — | — | 2 | — | — | — |
P/E ratio |
— | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | — |
Altman Z-Score |
— | — | — | — | — | 5.49 | (3.51) | (3.90) | (3.90) | — |
P/S ratio |
— | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | — |
Altman Z″-Score (non-manufacturers) |
— | — | — | — | — | 20.99 | (9.16) | (7.82) | (11.00) | — |
P/FCF ratio |
— | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | — |
Beneish M-Score |
— | — | — | — | — | — | (1.78) | — | — | — |
P/Operating CF |
— | — | — | — | — | (1,089.68) | (549.01) | 0.00 | 0.00 | — |
P/B ratio |
— | — | — | — | — | 165.93 | 282.16 | 0.00 | 0.00 | — |
Price to Tangible BV |
— | — | — | — | — | 223.63 | 653.72 | 0.00 | 0.00 | — |
EV/Sales |
— | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | — |
EV/EBITDA |
— | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | — |
EV/Operating CF |
— | — | — | — | — | (533.66) | (154.36) | 0.25 | 0.31 | — |
EV/FCF |
— | — | — | — | — | (529.55) | (154.05) | 0.25 | 0.31 | — |
Quick Ratio |
1.23 | 2.14 | 1.59 | 4.55 | 11.41 | 18.82 | 2.22 | 2.24 | 1.87 | 11.63 |
Current Ratio |
1.27 | 2.23 | 1.63 | 4.71 | 11.41 | 19.14 | 2.34 | 2.57 | 2.01 | 11.70 |
Net Debt/EBITDA |
0.35 | 0.79 | 0.70 | 1.43 | 2.67 | 4.45 | 0.92 | 0.85 | 0.62 | 2.04 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.07 | 0.07 | 0.01 | 0.00 |
Operating CF/Net income |
0.21 | 1.98 | 1.00 | 0.77 | 0.81 | 0.49 | 0.95 | 1.63 | 0.71 | 0.52 |
Capex/Depreciation |
(0.01) | 0.00 | (0.02) | (1.13) | (0.50) | (0.66) | (0.06) | (2.29) | (3.25) | (5.00) |
Interest Coverage |
(27.96) | (22.78) | (10.15) | (337.36) | (84.59) | (217.03) | (39.54) | (13.59) | (460.23) | (117.75) |
| (123.97%) | (21.55%) | (48.85%) | (38.62%) | (25.38%) | (61.80%) | (53.52%) | (52.81%) | (110.33%) | (106.29%) | |
| (96.63%) | (17.80%) | (40.19%) | (34.72%) | (23.88%) | (56.84%) | (39.74%) | (35.98%) | (83.70%) | (94.26%) | |
ROIC |
(20,189.71%) | (28.20%) | (73.71%) | (94.27%) | (62.60%) | (37.70%) | (100.19%) | (113.22%) | (596.87%) | 0.00% |
Return on Tangible Assets |
(1,179.53%) | (143.51%) | (318.54%) | (82.04%) | (41.31%) | (49.68%) | (122.03%) | (99.29%) | (301.56%) | (88.89%) |
Average Days of Receivables |
— | — | — | 0.00 | 0.00 | 0.00 | 544.00 | 270.24 | 0.00 | 0.00 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 267.40% | 526.80% | 4,640.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 607.80% | 519.50% | 6,397.00% | 0.00% |
Intangible Assets out of Total Assets |
0.42 | 0.75 | 0.63 | 0.38 | 0.29 | 0.24 | 0.42 | 0.42 | 0.44 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 127.30% | 77.30% | 2,308.00% | 0.00% |
Graham Net Nets |
— | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | — |
Graham Number |
— | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | — |
Earnings Yield |
— | — | — | — | — | (0.06%) | (4.22%) | (0.32%) | (199.77%) | — |
Free Cash Flow Yield |
— | — | — | — | — | (0.19%) | (0.65%) | 0.00% | 0.00% | — |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 103.09 | 140.85 | 21.28 | 0.00 |
Operating CF per Share |
(11.78) | (87.60) | (179.99) | (185.12) | (169.44) | (239.95) | (575.36) | (1,194.37) | (1,835.53) | (2,159.31) |
Capex per Share |
(0.01) | 0.00 | (0.03) | (2.52) | (1.31) | (2.71) | (1.13) | (2.25) | (2.77) | (3.45) |
Free Cash Flow per Share |
(11.79) | (87.60) | (180.02) | (187.64) | (170.75) | (242.66) | (576.49) | (1,196.62) | (1,838.30) | (2,162.76) |
Cash per Share |
19.94 | 51.98 | 139.22 | 355.23 | 537.59 | 1,005.30 | 659.28 | 941.41 | 1,581.91 | 5,054.14 |
Shareholders Equity per Share |
20.12 | 200.68 | 309.82 | 521.00 | 741.53 | 1,386.99 | 1,119.48 | 1,549.86 | 1,848.51 | 4,615.52 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
20.12 | 200.68 | 309.82 | 521.00 | 741.53 | 1,386.99 | 1,119.48 | 1,549.86 | 1,848.51 | 4,615.52 |
Free Cash Flow |
(5.66) | (14.37) | (19.93) | (16.96) | (14.99) | (13.95) | (5.59) | (8.50) | (8.64) | (6.27) |
Working Capital |
2.11 | 4.92 | 6.09 | 26.20 | 44.22 | 56.18 | 4.76 | 5.20 | 4.01 | 13.63 |
Capital Expenditures |
0.00 | — | 0.00 | (0.23) | (0.11) | (0.16) | (0.01) | (0.02) | (0.01) | (0.01) |
Net Current Asset Value |
1.95 | 4.78 | 5.78 | 25.73 | 43.38 | 55.23 | 4.44 | 4.80 | 2.49 | 13.37 |
EV/EBIT |
— | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | — |
Capex to Sales |
0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.02 | 0.13 | 0.00 |
Price to Operating Income |
— | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Other line items | ||||||||||
Depreciation/Fixed assets |
1.64 | 1.50 | 1.28 | 0.93 | 0.83 | 1.32 | 4.68 | 0.19 | 0.14 | 0.13 |
Cash ROIC |
(29.42%) | (34.67%) | (40.09%) | (21.41%) | (13.35%) | (10.14%) | (32.41%) | (48.03%) | (53.59%) | (22.37%) |
Accounts Receivable Turnover |
— | — | — | 0.00 | 0.00 | 0.00 | 0.90 | 2.24 | 0.00 | 0.00 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | — | — | 0.00 | 0.00 | 0.00 | — | — | 0.00 | 0.00 |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | — | — | 0.00 | 0.00 | 0.00 | — | — | 0.00 | 0.00 |
Average Receivables |
— | — | — | 1.21 | 0.89 | 1.00 | 1.12 | 0.45 | — | 0.20 |
Average Payables |
1.76 | 2.49 | 2.83 | 1.80 | 1.34 | 1.22 | 0.98 | 0.46 | 0.37 | 0.43 |
Average Assets |
27.31 | 40.67 | 49.46 | 62.41 | 77.00 | 49.26 | 14.72 | 14.45 | 14.55 | 12.86 |
Average Common Equity |
21.29 | 33.60 | 40.70 | 56.10 | 72.43 | 45.31 | 10.93 | 9.85 | 11.04 | 11.41 |
Columns are period end dates